Description: Revive Therapeutics Ltd. is focused on commercializing treatments for rare diseases such as Cystinuria, Wilson's disease and Rett syndrome. Additional information on Revive is available at www.ReviveThera.com.
Home Page: www.revivethera.com
The Canadian Venture Building
Toronto,
ON
M5C 1P1
Canada
Phone:
888 901 0036
Officers
| Name | Title |
|---|---|
| Mr. Michael Frank | Chairman & CEO |
| Mr. Carmelo Marrelli ACIS, B.Comm., CA, CGA, CPA | Chief Financial Officer |
| Dr. Kelly T. McKee Jr., M.D., M.P.H. | Chief Scientific Officer Consultant |
| Dr. Onesmo Mpanju Ph.D. | Chief Regulatory Affairs Consultant |
| Mr. Derrick Alexander Welsh | COO of Psilocin Pharma |
Exchange: OTCQB
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.9957 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |